Cadence Welcomes Bob White to Board of Directors
Cadence, a leading provider of contract manufacturing solutions for MedTech and Pharma markets, has appointed Bob White to its Board of Directors. White brings over 25 years of business leadership experience, with a focus on operational excellence, technological innovation, and strategic growth. He previously served as Executive Vice President and Group President at Medtronic, managing five global businesses across 70 countries. White's experience includes:
- Leading 25,000 employees and 13 manufacturing facilities
- Achieving consistent above-market growth
- Completing seven acquisitions, a joint venture, and a multi-billion-dollar divestiture
White currently serves as an Independent Director for Smith & Nephew (NYSE: SNN) and holds an MBA from Case Western Reserve University. His appointment is expected to contribute significantly to Cadence's strategic goals and market approach.
Cadence, un importante fornitore di soluzioni di produzione su contratto per i mercati MedTech e Pharma, ha nominato Bob White nel suo Consiglio di Amministrazione. White porta con sé oltre 25 anni di esperienza nella leadership aziendale, concentrandosi sull'eccellenza operativa, l'innovazione tecnologica e la crescita strategica. Ha precedentemente ricoperto il ruolo di Vicepresidente Esecutivo e Presidente di gruppo presso Medtronic, gestendo cinque affari globali in 70 paesi. L'esperienza di White include:
- Leading 25.000 dipendenti e 13 stabilimenti di produzione
- Raggiungendo una crescita costante superiore al mercato
- Completando sette acquisizioni, una joint venture e una dismissione da miliardi di dollari
White attualmente ricopre il ruolo di Direttore Indipendente per Smith & Nephew (NYSE: SNN) e possiede un MBA dalla Case Western Reserve University. La sua nomina si prevede contribuirà significativamente agli obiettivi strategici e all'approccio di mercato di Cadence.
Cadence, un proveedor líder de soluciones de fabricación por contrato para los mercados de MedTech y Pharma, ha nombrado a Bob White en su Junta Directiva. White aporta más de 25 años de experiencia en liderazgo empresarial, con un enfoque en la excelencia operativa, la innovación tecnológica y el crecimiento estratégico. Anteriormente, se desempeñó como Vicepresidente Ejecutivo y Presidente de Grupo en Medtronic, gestionando cinco negocios globales en 70 países. La experiencia de White incluye:
- Liderar 25,000 empleados y 13 instalaciones de fabricación
- Lograr un crecimiento constante por encima del mercado
- Completar siete adquisiciones, una empresa conjunta y una desinversión de miles de millones de dólares
White actualmente se desempeña como Director Independiente para Smith & Nephew (NYSE: SNN) y tiene un MBA de la Case Western Reserve University. Se espera que su nombramiento contribuya significativamente a los objetivos estratégicos y al enfoque de mercado de Cadence.
Cadence는 MedTech 및 Pharma 시장을 위한 계약 제조 솔루션의 주요 제공업체로, Bob White를 이사회에 임명하였습니다. White는 운영 우수성, 기술 혁신 및 전략적 성장을 중점으로 한 비즈니스 리더십 경험을 25년 이상 보유하고 있습니다. 그는 이전에 Medtronic의 수석 부사장 및 그룹 사장으로 재직하며 70개국에서 5개의 글로벌 비즈니스를 관리했습니다. White의 경험에는 다음이 포함됩니다:
- 25,000명의 직원과 13개의 제조 시설 관리
- 지속적으로 시장 성장률을 초과 달성
- 7건의 인수 및 합작 투자, 수십억 달러 규모의 매각 완료
White는 현재 Smith & Nephew (NYSE: SNN)의 독립 이사로 재직 중이며, Case Western Reserve University에서 MBA를 보유하고 있습니다. 그의 임명은 Cadence의 전략적 목표 및 시장 접근 방식에 상당한 기여를 할 것으로 예상됩니다.
Cadence, un fournisseur majeur de solutions de fabrication contractuelle pour les marchés MedTech et Pharma, a nommé Bob White au Conseil d'Administration. White possède plus de 25 ans d'expérience en leadership d'entreprise, avec un accent sur l'excellence opérationnelle, l'innovation technologique et la croissance stratégique. Il a précédemment occupé le poste de vice-président exécutif et de président de groupe chez Medtronic, gérant cinq entreprises mondiales dans 70 pays. L'expérience de White comprend :
- La direction de 25 000 employés et de 13 usines de production
- L'atteinte d'une croissance constante supérieure à celle du marché
- La réalisation de sept acquisitions, d'une coentreprise et d'une cession de plusieurs milliards de dollars
White est actuellement directeur indépendant pour Smith & Nephew (NYSE: SNN) et détient un MBA de la Case Western Reserve University. On s'attend à ce que sa nomination contribue de manière significative aux objectifs stratégiques de Cadence et à son approche du marché.
Cadence, ein führender Anbieter von Vertragsfertigungslösungen für die MedTech- und Pharma-Märkte, hat Bob White in seinen Vorstand berufen. White bringt über 25 Jahre Erfahrung in der Unternehmensführung mit, wobei der Schwerpunkt auf operativer Exzellenz, technologischen Innovationen und strategischem Wachstum liegt. Zuvor war er als Executive Vice President und Group President bei Medtronic tätig und leitete fünf globale Geschäftseinheiten in 70 Ländern. Whites Erfahrungen umfassen:
- Führung von 25.000 Mitarbeitern und 13 Fertigungsstätten
- Erzielung eines konstanten Wachstums über dem Marktdurchschnitt
- Abschluss von sieben Akquisitionen, einem Joint Venture und einer mehr Milliarden Dollar umfassenden Abspaltung
White ist derzeit als unabhängiger Direktor für Smith & Nephew (NYSE: SNN) tätig und besitzt einen MBA der Case Western Reserve University. Seine Berufung wird voraussichtlich erheblich zu Cadences strategischen Zielen und Marktansatz beitragen.
- Appointment of Bob White, an experienced business leader, to the Board of Directors
- White's extensive experience in managing global operations and driving growth
- Track record of successful acquisitions and divestitures
- Current role as Independent Director for Smith & Nephew (NYSE: SNN)
- None.
Mr. White has demonstrated exceptional skills in managing global locations, having held senior positions at Medtronic, GE Healthcare, and IBM. He recently served as Executive Vice President and Group President for Medtronic, where he led five global businesses with 25,000 employees across 70 countries and 13 manufacturing facilities, achieving consistent above-market growth. During his tenure, he also successfully completed seven acquisitions, a joint venture, and a multi-billion-dollar divestiture.
"Bob will be an excellent addition to our Board," stated Matt Jennings, Cadence's Chairman of the Board. "His impressive track record in global business leadership and his commitment to innovation and growth will be instrumental as Cadence continues to advance its strategic goals and drive success, and he will be valuable to both the Board and Cadence's leadership team with their go-to market approach."
In addition, Mr. White currently serves as an Independent Director for Smith & Nephew (NYSE: SNN) and formerly held board positions at Mozarc Medical and CARE Hospitals, a multi-specialty healthcare provider with 14 hospitals in six cities across five states of
He holds an MBA from Case Western Reserve University and a Bachelor of Business Administration from Cleveland State University. His extensive medical device manufacturing experience and strategic vision make him a valuable addition to Cadence's Board of Directors.
About Cadence, Inc. – Cadence is a vertically integrated, medical device contract manufacturing organization serving the medical device, diagnostics, and drug delivery markets, providing best-in-class product design and development support through complete manufacturing of finished devices. Cadence employs approximately 800 people worldwide with its corporate headquarters in
View original content to download multimedia:https://www.prnewswire.com/news-releases/cadence-welcomes-bob-white-to-board-of-directors-302246732.html
SOURCE Cadence, Inc.
FAQ
Who is Bob White and what experience does he bring to Cadence's Board of Directors?
How might Bob White's appointment impact Cadence's future strategy?
What is Bob White's connection to Smith & Nephew (NYSE: SNN)?